Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) MIDAZOLAM CLARIS midazolam (as hydrochloride) 5 mg/5 ml solution for injection
Section 19A approved medicine
(Approval lapsed) MIDAZOLAM CLARIS midazolam (as hydrochloride) 5 mg/5 ml solution for injection
Section 19A approval holder
Baxter Healthcare Pty Ltd ABN 43 000 392 781
Phone
1800 229 837
Approved until
Status
Expired
Medicines in short supply/unavailable
Midazolam-Baxter midazolam (as hydrochloride) 5mg/5 mL solution for injection ampoule - ARTG 216025
MIDAZOLAM ACCORD midazolam (as hydrochloride) 5 mg/ 5 mL solution for injection ampoules - ARTG 207239
MIDAZOLAM ACCORD midazolam (as hydrochloride) 5 mg/ 5 mL solution for injection ampoules - ARTG 207239
Indication(s)
- IM - premedication before induction of anaesthesia
- IV - conscious sedation before diagnostic or short surgical, diagnostic, therapeutic or endoscopic procedures
- IV - sedation in intensive care units (I.V. administration as bolus injection or continuous infusion)
- IV - induction and maintenance of anaesthesia
Additional information
MIDAZOLAM-CLARIS midazolam (as hydrochloride) 5 mg/5 mL solution for injection is not indicated for oral, intranasal or rectal use.